Skip to main content

Science Welcomes Nevada Sanchez as Executive Vice President of Engineering

As we continue to make progress on our key goals, I’m excited to announce the appointment of Nevada Sanchez as Executive Vice President of Engineering. Nevada will provide leadership across the Science engineering organizations and will report directly to me.

Nevada co-founded Butterfly Network, Inc. in 2011, and until recently served as Senior Vice President and Chief Innovation Officer. While there, he conceived and led the development of the world’s first ultrasound system on a chip, building the engineering organization that took the technology from a prototype to a globally deployed platform. His work helped establish Butterfly as a pioneer in semiconductor-based medical imaging. Nevada holds an S.B. in Electrical Engineering and Computer Science, an S.B. in Mathematics with a minor in Physics, and an M.Eng. in Electrical Engineering and Computer Science from MIT.

Earlier this year we raised a $230 million Series C, and Nevada joins us at a time of significant growth and transition in the company’s life and as we begin the European commercial launch of PRIMA, our BCI retinal implant. We are also accelerating development of our Biohybrid neural interface and Vessel perfusion programs, and expanding the Science Foundry, with its comprehensive MEMS fabrication capabilities.

Our team is dedicated to solving some of medicine’s hardest problems through neural engineering. This requires constant innovation at scale and the best minds working together. Nevada has spent the past fifteen years creating an entirely new sensing technology at Butterfly and scaling it to a product used by clinicians globally to reveal what was previously invisible.

Nevada brings exactly the kind of cross-disciplinary engineering leadership required to turn ambitious scientific ideas into products that work reliably in the real world. I’m excited to welcome him to Science and to see the impact he will have on our team, our technology, and ultimately the patients we serve.

Author

  • Max Hodak, CEO

Published

July 29, 2026